Travere Therapeutics to Report Second Quarter 2022 Financial Results

SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter 2022 financial results on Thursday, August 4, 2022 before the open of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 8:00 a.m. ET. Conference Call Information                            Date: Thursday, August 4, 2022Time:      8:00 a.m. ETDial-in numbers: +1 (888) 220-8474 (U.S.) or +1 (313) 209-6544 (International)Confirmation code: 5371785Live webcast: Travere.com in the “Events & Presentations” section of the “Investors” page A replay of the call will be available from 11:00 a.m. ET, August 4, 2022, to 11:00 a.m. ET, August 11, 2022. The replay number is +1 (888) 203-1112 (U.S.) or +1 (719) 457-0820 (International), confirmation code 5371785. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com Contact:Chris Cline, CFA                                 Senior Vice President, Investor Relations & Corporate Communications888-969-7879                                        [email protected]